Concepedia

Aya Maeda

AM

4

Publications

161

Citations

4

H-Index

2015

Active since

Affiliations

Saga University(Current)

The University of Texas MD Anderson Cancer Center

PTC Therapeutics (United States)

Kameda Medical Center

Aya Maeda is an author at Saga University specializing in tumor biology, cancer research, and medicine.

Top concepts

Publications per year

2015–2018

4

Publications

4

The novel BMI-1 inhibitor PTC596 downregulates MCL-1 and induces p53-independent mitochondrial apoptosis in acute myeloid leukemia progenitor cells

Yuichiro Nishida, Aya Maeda, M J Kim et al. · Blood Cancer Journal · 2017 · 103 citations · Full text

Preclinical activity of the novel B‐cell‐specific Moloney murine leukemia virus integration site 1 inhibitor <scp>PTC</scp>‐209 in acute myeloid leukemia: Implications for leukemia therapy

Yuki Nishida, Aya Maeda, Dhruv Chachad et al. · Cancer Science · 2015 · 27 citations · Full text

, , +18

Targeting of BMI-1 expression by the novel small molecule PTC596 in mantle cell lymphoma

Aya Maeda, Yuki Nishida, Marla Weetall et al. · Oncotarget · 2018 · 18 citations · Full text

The pathophysiological significance of PPM1D and therapeutic targeting of PPM1D-mediated signaling by GSK2830371 in mantle cell lymphoma

Kensuke Kojima, Aya Maeda, Mariko Yoshimura et al. · Oncotarget · 2016 · 13 citations · Full text

, , +20

Rows per page

1–4 of 4